Additional file 5: of A pharmacogenetic signature of high response to Copaxone in late-phase clinical-trial cohorts of multiple sclerosis

The eleven-SNP model coefficients, odds ratios with 95% Bayesian confidence intervals and posterior inclusion probabilities. (DOCX 15 kb)